약학회지
YAKHAK HOEJI
ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)

Table. 5.

Table. 5.

The number of approved cases by conditions in South Korea from 2016 to March, 2021

Condition Number of approvals, n (%)
Idiopathic pulmonary fibrosis 885 (26.99)
Lung cancer 854 (26.04)
Pancreatic cancer 306 (9.33)
Breast cancer 236 (7.2)
Liver cancer 140 (4.27)
Atopic dermatitis 106 (3.23)
Melanoma 70 (2.13)
Coronavirus disease 2019 (COVID-19) 68 (2.07)
Leukemia 68 (2.07)
Glioblastoma 56 (1.71)
Multiple myeloma 49 (1.49)
Graft-versus-host reaction or disease (GVHD) 41 (1.25)
Ovarian cancer 41 (1.25)
Others 359 (10.95)
Yakhak Hoeji 2021;65:441-52 https://doi.org/10.17480/psk.2021.65.6.441
© 2021 Yakhak Hoeji